Qantas (ASX:QAN) focusing on repair and recovery

03Dec

Qantas (ASX:QAN) focusing on repair and recovery

 

Qantas (ASX:QAN) has started to repair its balance sheet as it sees Group Domestic capacity at 68 per cent of pre-COVID levels for December, rising to nearly 80 per cent for Quarter Three.

While the Group will post a substantial loss for FY21, it expects to be close to break even at the Underlying EBITDA level for the first half and net free cash flow positive (excluding redundancies) in the second half – allowing the repair process to begin.

Progress on vaccines provides additional consumer confidence.

The recovery plan announced in June this year is on track to deliver $600 million in structural cost benefits in FY21, reaching at least $1 billion in annual cost improvements from FY23 onwards.

Shares in Qantas (ASX:QAN) closed 1.5 per cent higher at $5.55 yesterday.

Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

04Sep

Christine O’Reilly retires from Transurban (ASX:TCL) board

04 Sep 2020 - Transurban (ASX:TCL) non-executive director Christine O’Reilly will retire from the group’s board at the conclusion of the 2020 annual general meeting on 8 October 2020.

Read More
08Apr

Worley (ASX:WOR) inks deal to build Phillips 66 renewable fuel factory

08 Apr 2021 - Engineering service provider Worley (ASX:WOR) has inked a deal with US Energy producer Phillips 66 to reconfigure a San Francisco refinery into a renewable fuels-manufacturing facility.

Read More
30Sep

Recce Pharmaceuticals (ASX:RCE) in an agreement with Murdoch Childrens Institute

30 Sep 2020 - Recce Pharmaceuticals (ASX:RCE) has entered into an agreement with the Murdoch Children’s Research Institute to conduct pre-clinical studies assessing the potential of RECCE 435 (R435) for the treatment of Helicobacter pylori infections.

Read More
28Aug

Stocks of the Hour: Wesfarmers, Integral Diagnostics & Mayne Pharama

27 Aug2021 - A snapshot of the stocks on the move, featuring Wesfarmers (ASX:WES), Integral Diagnostics (ASX:IDX) & Mayne Pharma (ASX:MYX).

Read More
03Feb

Invion (ASX:IVX) secures services agreement with Pavay Biotech

03 Feb 2020 - A subsidiary of Invion (ASX:IVX), EpiTech Dermal Science, has signed an R&D services agreement with a leading China-based pharmaceutical group in the skin repair and treatment market.

Read More
27Jul

St Barbara (ASX:SBM) subsidiary to acquire Moose River Resources

27 Jul 2020 - Gold producer and explorer, St Barbara (ASX:SBM) has agreed to acquire Moose River Resources Incorporated through its wholly owned subsidiary Atlantic Mining.

Read More
12Jan

PolyNovo (ASX:PNV) sales rise despite slow November and December

12 Dec 2021 - PolyNovo (ASX:PNV) has reported an increase in sales of 31 per cent in the first half of the 2021 financial year.

Read More
07Sep

Westpac to defend class action by Slater & Gordon

06 Sep 2019 - Westpac (ASX:WBC) today confirmed that it has received a class action filed against its subsidiary companies, BT Funds Management (BTFM) and Westpac Life Insurance Services (WLIS) filed by law firm Slater and Gordon.

Read More
28Jul

Stocks of the Hour: Laybuy Holdings, Euro Manganese, ELMO Software

28 Jul 2022 - A snapshot of the stocks on the move featuring Laybuy Holdings (ASX:LBY), Euro Manganese (ASX:EMN) and ELMO Software (ASX:ELO).

Read More
12Mar

DGR Global (ASX:DGR) pens deal for Auburn Resources to acquire Armours Ripple Resources

12 Mar 2021 - DGR Global (ASX:DGR) has signed a deal with Auburn Resources and Armour Energy (ASX:AJQ) which will see Auburn acquire Armour’s wholly owned subsidiary, Ripple Resources.

Read More